Erythritol (20 g in solution) was administered orally in a single-dose to 5 patients with diabetes. Serum Test Substance erythritol levels reached a peak 1 hr after administraErythritol powder ( §99% purity) was obtained from tion and then declined rapidly. Total urinary excretion Nikken Chemicals Co., Ltd., Tokyo. School of Medicine, were the subjects of this study. The was administered orally daily for 14 days to 11 patients with diabetes. Mean serum glucose and hemoglobin mean age of the patients was 52.4 { 19.2 years, and A1c levels decreased over the time period. Indices of the mean duration of their diabetes was 5.0 { 4.6 years. renal function-blood urea nitrogen, creatinine, and All subjects relied only on dietary therapy as treatb2-microglobulin-did not change significantly. The ment, and none showed any sign of hepatic dysfunction.
INTRODUCTION
6, 8, and 24 hr after erythritol administration. Subjects were allowed to eat food 3 hr after administration of More than 90% of an ingested dose of erythritol is the test solution. Urine was collected 24 hr before and excreted unchanged in the urine, indicating that, in 0-24, 24-48, and 48-72 hr after erythritol adminishumans, erythritol is efficiently absorbed, not metabo-tration. lized, and excreted by renal processes (Noda et al., Blood samples were analyzed for glucose, insulin, 1994). Consequently, the sweetener has potential value free fatty acids (nonesterified fatty acids, NEFA), 3-in the diets of patients with diabetes, who frequently hydroxybutyric acid (3-OHBA), and erythritol. Urine show a craving for sweets, which can adversely affect was analyzed for erythritol. Blood glucose was anablood glucose levels. In the present study, the effects lyzed by the glucose oxidase (GOD) electrode method, of single and continuous (14-day) oral doses of erythri-insulin by a standard radioimmunoassay method, and tol on blood glucose levels and associated parameters NEFA and 3-OHBA by standard enzymatic methods. were measured. Since most of the ingested erythritol Erythritol was analyzed in blood and urine by gas chrois excreted in the urine via the kidneys, the effect of matography (GC). erythritol loading on the kidneys was also examined.
Urine samples were desalted with Amberlite MB-3 and centrifuged at 2000 rpm for 2 min. Serum samples were rpm for 15 min. The supernatants were dried under a throughout the day with the subjects' usual diet, but there were no specific restrictions as to the timing or nitrogen stream. Erythritol in the dried samples was acetylated with acetic anhydride:pyridine (2:1) at 80ЊC for division of the daily dose. Food intake was monitored 3 days pretest and 3 days before completing adminis-20 min. Water was added to the resultant mixture and the solution partitioned with hexane:chloroform (3:1). tration. Blood samples were taken twice-before the first dose and after the final dose. The organic phase was dried with sodium sulfate and evaporated to dryness, and the acetylated erythritol was Body weight, fasting blood sugar (FBS), and hemoglobin A1c (HbA1c) were measured as indices of diabetaken up in 200 ml acetone. Five microliters of the solution was injected into the gas chromatograph (Shimadzu tes control and blood urea nitrogen (BUN), creatinine, b2-microglobulin (b2-MG), and urinary proteins as in-GC-15, equipped with a flame ionization detector) and glass column packed with 5% SP-2340 on Chromosorb W dices of renal function. Blood/serum analyses for these substances were done using standard clinical methods: (AW-DMCS) 60/80 mesh. Pentaerythritol and methyl-a-D-mannopyranoside were the internal standards used for FBS and BUN by enzymatic methods, HbA1c by an HPLC method, creatinine by the Jaffé reaction, b2-MG serum and urine analysis, respectively.
by radioimmunoassay, and urinary protein by colorimStatistical analysis. Repeated-measures analysis of etry (Pyrogallol-Red method). (Due to experimental variance was used to test the significance of changes convenience, all parameters were not determined for in the various blood and urine parameters during the every participant. For example, b2-MG was detercourse of the experiment. mined in the blood/serum of only four subjects.)
Fourteen-Day Ingestion Test
Statistical analyses. The paired t test using a significance level of P õ 0.05 was used to assess the sigSubjects. The subjects in this study were 11 nificance of observed changes. NIDDM outpatients (three males, mean age 65 { 6 years; eight females, mean age 50 { 14 years). They
RESULTS
were fully informed about the nature of the study and freely participated.
Single Oral Load Test
No subject reported adverse effects from consumpTest procedure. The subjects received 20 g erythritol/day for 14 days. The dose was ingested in solution tion of 20 g erythritol. No changes were observed in blood glucose and insu-kg to a postdosing mean of 58.1 { 9.5 kg (mean weight lin from 0.5 to 3 hr, compared to preadministration of seven individuals, n Å 7). Single-day FBS readings levels (baseline). Food was taken between 3 and 4 hr, pretest and posttest indicated maintenance of serum and the blood glucose level rose to 233.8 { 44.0 mg/dl glucose in four of nine subjects and changes in five of at 4 hr, compared to a preload level of 123.8 { 15.5 nine subjects (three decreasing and two increasing); mg/dl (Fig. 1) . Insulin rose significantly after ingestion group average FBS decreased from a predosing mean of of food to a level of 26.4 { 9.0 mU/ml, compared to a 181 { 60 mg/dl to a postdosing mean of 165 { 57 mg/ baseline level of 6.4 { 3.3 mU/ml (Fig. 2) . dl (n Å 9), but this change was not significant. The de-NEFA did not change significantly 3 hr after admin-crease was due to large drops in individuals with iniistration, compared to a baseline level of 0.6 { 0.2 mEq/ tially high FBS levels. HbA1c readings remained at preliter, but decreased to 0.2 { 0.1 mEq/liter after inges-test levels for 4 of 11 subjects, decreased in 6 of 11 subtion of food (Fig. 3) . 3-OHBA tended to increase over 3 jects, and increased in 1 of 11 subjects; the group mean hr from a value of 79.0 { 54.6 mM/liter before adminis-HbA1c levels declined significantly (P õ 0.05) from a tration, but dropped to 11.9 { 11.9 mM/liter after inges-predosing mean of 8.5 { 1.5% to a postdosing mean of tion of food (Fig. 4) . 7.5 { 1.6% (n Å 11), but, again, most of this decrease The peak serum erythritol concentration (649.4 { was due to large decreases in a few individuals. Two-37.4 mg/ml) was achieved 1 hr after administration. week administration of erythritol, therefore, had no adMost of the erythritol (81.99 { 3.7%) was eliminated verse effect on body weight or blood glucose control. in the urine within 24 hr (Fig. 5) . The percentage rose BUN, an index of renal function, showed no signifito almost 90% at 72 hr (Table 1) .
cant postdosing changes, either in one patient whose predosing levels were higher than the normal levels of Fourteen-Day Ingestion Test 21 mg/dl or in four patients with normal levels. The predosing group mean of 15.3 { 5.0 mg/dl (n Å 5) did Body weight dropped in three of seven subjects and not significantly differ from the postdosing mean of remained constant in the other four. As a result, the 14.0 { 7.3 mg/dl. Similarly, changes in creatinine levels group average body weight was nonsignificantly decreased from a preadministration mean of 60.8 { 11.6 were not judged to be significant. The predosing group mean creatinine level was 0.9 { 0.2 mg/dl (n Å 5), NEFA and 3-OHBA after erythritol administration followed by decreases after ingestion of food probably ocvirtually unchanged from the postdosing mean of 0.8 { 0.2 mg/dl. Levels of b2-MG did not change signifi-curred because no energy was supplied under erythritol load, placing the subjects in a state of hunger. cantly in four patients (n Å 4) who had predosing levels higher than 1.9 mg/liter. Likewise, there were no post-
The results are similar to those from a study in which single doses of 0.3 g/kg body wt erythritol or glucose dosing changes in urinary proteins. The indices of renal were ingested in one dose by five healthy males (Noda functions in diabetes patients thus showed no signifiet al., 1994) . Only slight changes in serum glucose or cant changes after daily administration of 20 g erythriinsulin levels were observed on ingestion of erythritol, tol for 14 days.
in contrast to ingestion of glucose. NEFA did not significantly rise after erythritol ingestion but did decline DISCUSSION AND CONCLUSIONS after a meal was taken at 3 hr. Erythritol did not induce The single dose study suggests that erythritol exerts any significant effects on serum levels of total cholesno effect on the metabolic system of diabetic patients. terol, triacylglycerol, Na, K, and Cl. The Noda et al. No significant changes were observed in blood glucose study also showed a cumulative urinary erythritol excretion level of about 90%. and insulin until ingestion of food. The increases in Daily (14-day) administration of erythritol had no may safely be a part of the diet of diabetics when used significant effect on blood glucose levels, nor were there at these levels. any significant effects observed on renal function. The significant decline in HbA1C, which provides an inte-REFERENCE grated index of the glycemic state, is an indication that erythritol may be helpful in long-term glucose control. Noda, K., Nakayama, K., and Oku, T. (1994) . Serum glucose and
The findings of the current study and those of the insulin levels and erythritol balance after oral administration of erythritol in healthy subjects. Eur. J. Clin. Nutr. 48, 286-292.
